Escherichia coli as a cell factory for heterologous production of nonribosomal peptides and polyketides

New Biotechnology

Volumn 31, Issue 6, 2014, Pages 579-585

  Li, Jian ^a,b   Neubauer, Peter ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

^b Northwestern University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METABOLIC ENGINEERING; MICROORGANISMS; PEPTIDES; PRODUCTIVITY;

ANTICANCER ACTIVITIES; BIOPROCESS OPTIMIZATION; BIOSYNTHETIC PATHWAY; HETEROLOGOUS PRODUCTION; MULTIPLE STRATEGY; NONRIBOSOMAL PEPTIDE; PHARMACEUTICAL APPLICATIONS; SYNTHETIC BIOLOGY;

ESCHERICHIA COLI;

6 METHYLSALICYLIC ACID; ANTHRAQUINONE; AUREUSIMINE A; AUREUSIMINE B; ECHINOMYCIN; ECOLIMYCIN C; EPOTHILONE C; EPOTHILONE D; ERYTHROMYCIN; ERYTHROMYCIN C; ERYTHROMYCIN D; LYNGBYATOXIN; NONRIBOSOMAL PEPTIDE; PEPTIDE; POLYKETIDE; TRIOSTIN A; UNCLASSIFIED DRUG; VALINOMYCIN; YERSINIABACTIN;

ARTICLE; BACTERIAL CELL; BATCH REACTOR; BIOPROCESS; BREVIBACILLUS BREVIS; DRUG STRUCTURE; ESCHERICHIA COLI; FED BATCH FERMENTATION; HETEROLOGOUS EXPRESSION; METABOLIC ENGINEERING; NONHUMAN; NONRIBOSOMAL PEPTIDE SYNTHESIS; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; SACCHAROPOLYSPORA; SORANGIUM CELLULOSUM; YERSINIA PESTIS; GENETICS; METABOLISM; PEPTIDE SYNTHESIS;

ESCHERICHIA COLI; PEPTIDE BIOSYNTHESIS; POLYKETIDES;

EID: 84910053480     PISSN: 18716784     EISSN: 18764347     Source Type: Journal    
DOI: 10.1016/j.nbt.2014.03.006     Document Type: Article

References (57)

1. Dias D.A., Urban S., Roessner U. A historical overview of natural products in drug discovery. Metabolites 2012, 2:303-336.
2. Newman D.J., Cragg G.M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012, 75:311-335.
3. Newman D.J., Cragg G.M., Snader K.M. The influence of natural products upon drug discovery. Nat Prod Rep 2000, 17:215-234.
4. Cane D.E., Walsh C.T. The parallel and convergent universes of polyketide synthases and nonribosomal peptide synthetases. Chem Biol 1999, 6:R319-R325.
5. Cane D.E., Walsh C.T., Khosla C. Harnessing the biosynthetic code: combinations, permutations, and mutations. Science 1998, 282:63-68.
6. Fischbach M.A., Walsh C.T. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 2006, 106:3468-3496.
7. Walsh C.T. Polyketide and nonribosomal peptide antibiotics: modularity and versatility. Science 2004, 303:1805-1810.
8. Galm U., Shen B. Expression of biosynthetic gene clusters in heterologous hosts for natural product production and combinatorial biosynthesis. Expert Opin Drug Discov 2006, 1:409-437.
9. Ongley S.E., Bian X., Neilan B.A., Müller R. Recent advances in the heterologous expression of microbial natural product biosynthetic pathways. Nat Prod Rep 2013, 30:1121-1138.
10. Zhang H., Boghigian B.A., Armando J., Pfeifer B.A. Methods and options for the heterologous production of complex natural products. Nat Prod Rep 2011, 28:125-151.
11. Zhang H., Wang Y., Pfeifer B.A. Bacterial hosts for natural product production. Mol Pharmaceut 2008, 5:212-225.
12. Huang C.J., Lin H., Yang X. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J Ind Microbiol Biotechnol 2012, 39:383-399.
13. Samuelson J.C. Recent developments in difficult protein expression: a guide to E. coli strains, promoters, and relevant host mutations. Methods Mol Biol 2011, 705:195-209.
14. Vincentelli R., Romier C. Expression in Escherichia coli: becoming faster and more complex. Curr Opin Struct Biol 2013, 23:326-334.
15. Ajikumar P.K., Xiao W-H., Tyo K.E.J., Wang Y., Simeon F., Leonard E., et al. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science 2010, 330:70-74.
16. Gao X., Wang P., Tang Y. Engineered polyketide biosynthesis and biocatalysis in Escherichia coli. Appl Microbiol Biotechnol 2010, 88:1233-1242.
17. Martin V.J.J., Pitera D.J., Withers S.T., Newman J.D., Keasling J.D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 2003, 21:796-802.
18. Li Y. Recombinant production of antimicrobial peptides in Escherichia coli: a review. Protein Expr Purif 2011, 80:260-267.
19. Lambalot R.H., Gehring A.M., Flugel R.S., Zuber P., LaCelle M., Marahiel M.A., et al. A new enzyme superfamily - the phosphopantetheinyl transferases. Chem Biol 1996, 3:923-936.
20. Quadri L.E.N., Weinreb P.H., Lei M., Nakano M.M., Zuber P., Walsh C.T. Characterization of Sfp, a Bacillus subtilis phosphopantetheinyl transferase for peptidyl carrier protein domains in peptide synthetases. Biochemistry 1998, 37:1585-1595.
21. Pfeifer B.A., Admiraal S.J., Gramajo H., Cane D.E., Khosla C. Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 2001, 291:1790-1792.
22. Watanabe K., Hotta K., Praseuth A.P., Koketsu K., Migita A., Boddy C.N., et al. Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli. Nat Chem Biol 2006, 2:423-428.
23. Gruenewald S., Mootz H.D., Stehmeier P., Stachelhaus T. In vivo production of artificial nonribosomal peptide products in the heterologous host Escherichia coli. Appl Environ Microbiol 2004, 70:3282-3291.
24. Praseuth A.P., Praseuth M.B., Oguri H., Oikawa H., Watanabe K., Wang C.C.C. Improved production of triostin A in engineered Escherichia coli with furnished quinoxaline chromophore by design of experiments in small-scale culture. Biotechnol Prog 2008, 24:134-139.
25. Watanabe K., Hotta K., Nakaya M., Praseuth A.P., Wang C.C.C., Inada D., et al. Escherichia coli allows efficient modular incorporation of newly isolated quinomycin biosynthetic enzyme into echinomycin biosynthetic pathway for rational design and synthesis of potent antibiotic unnatural natural product. J Am Chem Soc 2009, 131:9347-9353.
26. Watanabe K., Hotta K., Praseuth A.P., Searcey M., Wang C.C.C., Oguri H., et al. Rationally engineered total biosynthesis of a synthetic analogue of a natural quinomycin depsipeptide in Escherichia coli. ChemBioChem 2009, 10:1965-1968.
27. Wyatt M.A., Magarvey N.A. Optimizing dimodular nonribosomal peptide synthetases and natural dipeptides in an Escherichia coli heterologous host. Biochem Cell Biol 2013, 91:203-208.
28. Ongley S.E., Bian X., Zhang Y., Chau R., Gerwick W.H., Müller R., et al. High-titer heterologous production in E. coli of lyngbyatoxin, a protein kinase C activator from an uncultured marine cyanobacterium. ACS Chem Biol 2013, 8:1888-1893.
29. Li J., Jaitzig J., Hillig F., Süssmuth R., Neubauer P. Enhanced production of the nonribosomal peptide antibiotic valinomycin in Escherichia coli through small-scale high cell density fed-batch cultivation. Appl Microbiol Biotechnol 2014, 98:591-601.
30. Lau J., Tran C., Licari P., Galazzo J. Development of a high cell-density fed-batch bioprocess for the heterologous production of 6-deoxyerythronolide B in Escherichia coli. J Biotechnol 2004, 110:95-103.
31. Peirú S., Menzella H.G., Rodríguez E., Carney J., Gramajo H. Production of the potent antibacterial polyketide erythromycin C in Escherichia coli. Appl Environ Microbiol 2005, 71:2539-2547.
32. Zhang H., Skalina K., Jiang M., Pfeifer B.A. Improved E. coli erythromycin A production through the application of metabolic and bioprocess engineering. Biotechnol Prog 2012, 28:292-296.
33. Kealey J.T., Liu L., Santi D.V., Betlach M.C., Barr P.J. Production of a polyketide natural product in nonpolyketide-producing prokaryotic and eukaryotic hosts. Proc Natl Acad Sci U S A 1998, 95:505-509.
34. Zhang W., Li Y., Tang Y. Engineered biosynthesis of bacterial aromatic polyketides in Escherichia coli. Proc Natl Acad Sci U S A 2008, 105:20683-20688.
35. Mutka S.C., Carney J.R., Liu Y., Kennedy J. Heterologous production of epothilone C and D in Escherichia coli. Biochemistry 2006, 45:1321-1330.
36. Pfeifer B.A., Wang C.C.C., Walsh C.T., Khosla C. Biosynthesis of yersiniabactin, a complex polyketide-nonribosomal peptide, using Escherichia coli as a heterologous host. Appl Environ Microbiol 2003, 69:6698-6702.
37. Jaitzig J., Li J., Süssmuth R.D., Neubauer P. Reconstituted biosynthesis of the nonribosomal macrolactone antibiotic valinomycin in Escherichia coli. ACS Synth Biol 2013, 10.1021/sb400082j.
38. Matter A.M., Hoot S.B., Anderson P.D., Neves S.S., Cheng Y.Q. Valinomycin biosynthetic gene cluster in Streptomyces: conservation, ecology and evolution. PLoS ONE 2009, 4:e7194.
39. Murli S., Kennedy J., Dayem L.C., Carney J.R., Kealey J.T. Metabolic engineering of Escherichia coli for improved 6-deoxyerythronolide B production. J Ind Microbiol Biotechnol 2003, 30:500-509.
40. Pfeifer B., Hu Z., Licari P., Khosla C. Process and metabolic strategies for improved production of Escherichia coli-derived 6-deoxyerythronolide B. Appl Environ Microbiol 2002, 68:3287-3292.
41. Pistorino M., Pfeifer B.A. Efficient experimental design and micro-scale medium enhancement of 6-deoxyerythronolide B production through Escherichia coli. Biotechnol Prog 2009, 25:1364-1371.
42. Wang Y., Boghigian B., Pfeifer B. Improving heterologous polyketide production in Escherichia coli by overexpression of an S-adenosylmethionine synthetase gene. Appl Microbiol Biotechnol 2007, 77:367-373.
43. Heathcote M.L., Staunton J., Leadlay P.F. Role of type II thioesterases: evidence for removal of short acyl chains produced by aberrant decarboxylation of chain extender units. Chem Biol 2001, 8:207-220.
44. Kim B.S., Cropp T.A., Beck B.J., Sherman D.H., Reynolds K.A. Biochemical evidence for an editing role of thioesterase II in the biosynthesis of the polyketide pikromycin. J Biol Chem 2002, 277:48028-48034.
45. Zhang H., Boghigian B.A., Pfeifer B.A. Investigating the role of native propionyl-CoA and methylmalonyl-CoA metabolism on heterologous polyketide production in Escherichia coli. Biotechnol Bioeng 2010, 105:567-573.
46. Boghigian B.A., Zhang H., Pfeifer B.A. Multi-factorial engineering of heterologous polyketide production in Escherichia coli reveals complex pathway interactions. Biotechnol Bioeng 2011, 108:1360-1371.
47. Wang Y., Pfeifer B.A. 6-Deoxyerythronolide B production through chromosomal localization of the deoxyerythronolide B synthase genes in E. coli. Metab Eng 2008, 10:33-38.
48. Zhang H., Wang Y., Wu J., Skalina K., Pfeifer B.A. Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host. Chem Biol 2010, 17:1232-1240.
49. Julien B., Shah S., Ziermann R., Goldman R., Katz L., Khosla C. Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum. Gene 2000, 249:153-160.
50. Boddy C.N., Hotta K., Tse M.L., Watts R.E., Khosla C. Precursor-directed biosynthesis of epothilone in Escherichia coli. J Am Chem Soc 2004, 126:7436-7437.
51. Boghigian B., Pfeifer B. Current status, strategies, and potential for the metabolic engineering of heterologous polyketides in Escherichia coli. Biotechnol Lett 2008, 30:1323-1330.
52. Krause M., Ukkonen K., Haataja T., Ruottinen M., Glumoff T., Neubauer A., et al. A novel fed-batch based cultivation method provides high cell-density and improves yield of soluble recombinant proteins in shaken cultures. Microb Cell Fact 2010, 9:11.
53. Tegel H., Yderland L., Boström T., Eriksson C., Ukkonen K., Vasala A., et al. Parallel production and verification of protein products using a novel high-throughput screening method. Biotechnol J 2011, 6:1018-1025.
54. Ukkonen K., Vasala A., Ojamo H., Neubauer P. High-yield production of biologically active recombinant protein in shake flask culture by combination of enzyme-based glucose delivery and increased oxygen transfer. Microb Cell Fact 2011, 10:107.
55. Ukkonen K., Veijola J., Vasala A., Neubauer P. Effect of culture medium, host strain and oxygen transfer on recombinant Fab antibody fragment yield and leakage to medium in shaken E. coli cultures. Microb Cell Fact 2013, 12:73.
56. Amir-Heidari B., Thirlway J., Micklefield J. Auxotrophic-precursor directed biosynthesis of nonribosomal lipopeptides with modified tryptophan residues. Org Biomol Chem 2008, 6:975-978.
57. Powell A., Al Nakeeb M., Wilkinson B., Micklefield J. Precursor-directed biosynthesis of nonribosomal lipopeptides with modified glutamate residues. Chem Commun 2007, 26:2683-2685.